2025
Definitive radiation as a nonsurgical option after chemoimmunotherapy for stage III lung cancer.
Caturegli G, Canavan M, Ayoade O, Woodard G, Boffa D, Resio B. Definitive radiation as a nonsurgical option after chemoimmunotherapy for stage III lung cancer. Journal Of Clinical Oncology 2025, 43: 8072-8072. DOI: 10.1200/jco.2025.43.16_suppl.8072.Peer-Reviewed Original ResearchStage III non-small cell lung cancerIII non-small cell lung cancerNon-small cell lung cancerThree-year overall survivalNonsurgical optionsDefinitive radiationLocal therapyOverall survivalClinical stage III non-small cell lung cancerLung cancerClinical stage III patientsStage III NSCLC patientsStage III lung cancerSquamous cell carcinoma patientsStage III lung adenocarcinomaIII NSCLC patientsInitiation of radiationNon-operative formsCharlson-Deyo scoreIII lung cancerNational Cancer DatabaseStage III patientsTreated with radiationCell carcinoma patientsKaplan-Meier methodSurvival of patients diagnosed with stage IV cancer in 2020 based on COVID-19 status.
Ayoade O, Canavan M, Caturegli G, Zolfaghari E, Resio B, Woodard G, Boffa D. Survival of patients diagnosed with stage IV cancer in 2020 based on COVID-19 status. Journal Of Clinical Oncology 2025, 43 DOI: 10.1200/jco.2025.43.16_suppl.e24041.Peer-Reviewed Original ResearchCancer patient survivalPatient survivalTumor behaviorCOVID-19 infectionCancer typesCharlson-Deyo scoreNational Cancer DatabaseSurvival of patientsKaplan Meier analysisCox proportional hazards modelsStage IV cancerAssociated with lower mortality riskProportional hazards modelCOVID-positive patientsMeier analysisCancer DatabaseLower mortality riskPositive patientsTreatment modalitiesDeyo scoreIV cancerImmune modulationImmunological consequencesCancer patientsYear mortalityGender Disparities in Cardiothoracic Surgical Conference Scholarly Interactions: A Prime Opportunity for Change in Culture
Ries S, Zolfaghari E, Higaki A, Olivera J, Cangut B, Ahmed A, Hsiung T, Carducci J, Chidi A, Elshiekh M, Degife E, Arrington R, Jindani R, Perkins A, Rodriguez E, Eisenberg M, Servais E, Woodard G, Antonoff M. Gender Disparities in Cardiothoracic Surgical Conference Scholarly Interactions: A Prime Opportunity for Change in Culture. JTCVS Open 2025 DOI: 10.1016/j.xjon.2025.02.008.Peer-Reviewed Original ResearchAdult cardiac surgeryCardiac surgeryNo significant differenceGeneral thoracicWomen presentersSurgical meetingsSurgical residentsSignificant differenceObserved presentationWomenPresentationMenEvaluate presentationObservance of professional behaviorUnprofessional behaviorGender-related inequalitiesSurgeryLobectomy verses Sublobar Resection in The Society of Thoracic Surgeons Database: Importance of Patient Factors and Lymph Node Evaluation
Woodard G, Grau-Sepulveda M, Onaitis M, Udelsman B, David E, Jacobs J, Kosinski A, Blasberg J, Boffa D. Lobectomy verses Sublobar Resection in The Society of Thoracic Surgeons Database: Importance of Patient Factors and Lymph Node Evaluation. The Annals Of Thoracic Surgery 2025 PMID: 39864772, DOI: 10.1016/j.athoracsur.2025.01.004.Peer-Reviewed Original ResearchNon-small cell lung cancerSublobar resectionCell lung cancerLung cancerNodal upstagingImproved survivalHealthy patientsNode-negative non-small cell lung cancerThe Society of Thoracic Surgeons databaseRandomized trialsSociety of Thoracic Surgeons databaseAssociated with improved survivalEarly-stage lung cancerFewer lymph nodesInferior to survivalSublobar resection groupLymph node resectionThoracic Surgeons databaseLymph node evaluationProspective randomized trialsKaplan-Meier analysisForced expiratory volumeCT1 N0Pathologic upstagingNodal evaluationA Perspective on the MARS2 Trial
Lim E, Opitz I, Woodard G, Bueno R, de Perrot M, Flores R, Gill R, Jablons D, Pass H. A Perspective on the MARS2 Trial. Journal Of Thoracic Oncology 2025, 20: 262-272. PMID: 39772349, DOI: 10.1016/j.jtho.2024.12.014.Peer-Reviewed Original ResearchConceptsPleural mesotheliomaPleurectomy decorticationTrial interpretationAssemble individualsAssociated with worse survivalPhase 3 randomized controlled trialsTime of randomizationTeam leadersResectable PMHistological subtypesPreoperative stagingWorse survivalSurgical mortalityConsensus guidelinesTeamAdverse eventsFacilitationChemotherapyPayer's willingnessSurgical communityTrialsSurgeryMesotheliomaQuality assuranceDecortication
2024
The evolving landscape of adjuvant therapy in T1-T2N0 resected non-small cell lung cancer: a narrative review
Zolfaghari E, Dhanasopon A, Woodard G. The evolving landscape of adjuvant therapy in T1-T2N0 resected non-small cell lung cancer: a narrative review. Journal Of Thoracic Disease 2024, 0: 0-0. PMID: 39831209, PMCID: PMC11740046, DOI: 10.21037/jtd-24-245.Peer-Reviewed Original ResearchNon-small cell lung cancerEpidermal growth factor receptorEarly-stage non-small cell lung cancerAnaplastic lymphoma kinaseAdjuvant therapyCell lung cancerEarly-stage patientsSurgical resectionOverall survivalAdjuvant chemotherapyLung cancerSurvival benefit of adjuvant therapyAdjuvant platinum-based chemotherapyBenefit of adjuvant therapyHigh-risk pathologic featuresStage IB tumorsNational Clinical Trials RegistryPlatinum-based chemotherapyHigh-risk featuresCirculating tumor DNALandscape of adjuvant therapyLung cancer recurrenceGrowth factor receptorClinical Trials RegistryAdjuvant osimertinibLiving on the Edge: Role of Adjuvant Therapy After Resection of Primary Lung Cancer Within 2 Millimeters of a T-Stage Cutoff
Udelsman B, Bedrosian C, Kawaguchi E, Ding L, Wallace W, Rosenberg G, Harano T, Wightman S, Atay S, Kim A, Woodard G. Living on the Edge: Role of Adjuvant Therapy After Resection of Primary Lung Cancer Within 2 Millimeters of a T-Stage Cutoff. Journal Of Thoracic And Cardiovascular Surgery 2024 PMID: 39521371, DOI: 10.1016/j.jtcvs.2024.10.053.Peer-Reviewed Original ResearchNon-small cell lung cancerSystemic therapyOverall survivalT stageTumor sizeResected non-small cell lung cancerLung cancerNational Cancer Database of patientsResection of primary lung cancerOutcomes of systemic therapyPathologic tumor sizeNational Cancer DatabaseAdjuvant therapy useUse of systemic therapyPrimary lung cancerResection of tumorsCell lung cancerAssociated with decreased ratesDatabase of patientsRetrospective cohort studyTumor size distributionDownstaged patientsNodal involvementUnder-stagingAdjuvant therapy207 Spatial transcriptomic profiling non-small cell lung cancer reveals potential drivers of CTL exclusion and dysfunction, and identifies novel predictive biomarkers for checkpoint blockade therapy
Cho C, Lopez-Giraldez F, Huang B, He J, Woodard G, Badri T, Kidacki M, Vesely M, Wang G, Ofori-Ntiamoah G, Ng E, Chen L. 207 Spatial transcriptomic profiling non-small cell lung cancer reveals potential drivers of CTL exclusion and dysfunction, and identifies novel predictive biomarkers for checkpoint blockade therapy. 2024, a236-a236. DOI: 10.1136/jitc-2024-sitc2024.0207.Peer-Reviewed Original ResearchAirway Esophageal Fistula
Koch K, Dhanasopon A, Woodard G. Airway Esophageal Fistula. Thoracic Surgery Clinics 2024, 34: 405-414. PMID: 39332865, DOI: 10.1016/j.thorsurg.2024.07.005.Peer-Reviewed Original ResearchConceptsTracheoesophageal fistulaManagement of tracheoesophageal fistulaTreating tracheoesophageal fistulaAcquired tracheoesophageal fistulaFistula tractDefinitive treatmentSurgical repairSurgical approachSurgical methodsPrevent recurrenceMuscle flapTracheal stentPathological connectionIntensive careImprove outcomesFistulaDiagnostic toolRepairEsophagealRecurrenceEsophagusStentFlapSex-based differences in CEACAM5 expression in lung cancer
Woodard G, Kane E, Todorovic N, Prince S, Dacic S, Chen L. Sex-based differences in CEACAM5 expression in lung cancer. Translational Cancer Research 2024, 13: 6394-6402. PMID: 39697744, PMCID: PMC11651760, DOI: 10.21037/tcr-24-983.Peer-Reviewed Original ResearchMA08.12 Semi-Sold Lung Nodule Growth Rates, Need for Treatment, and Cancer-Specific Verses All-Cause Mortality in a Large North American Population
Woodard G, Kane E, Prince S, Blasberg J, Dhanasopon A, Boffa D, Mase V, Dacic S, Bader A, Detterbeck F. MA08.12 Semi-Sold Lung Nodule Growth Rates, Need for Treatment, and Cancer-Specific Verses All-Cause Mortality in a Large North American Population. Journal Of Thoracic Oncology 2024, 19: s87. DOI: 10.1016/j.jtho.2024.09.156.Peer-Reviewed Original ResearchEP.07C.10 Real-World Outcomes of Patients Treated with Neoadjuvant Immunotherapy for Resectable Non-Small Cell Lung Cancer
Ermer T, Kim S, Goldberg S, Zolfaghari E, Blasberg J, Boffa D, Herbst R, Politi K, Schalper K, Dacic S, Woodard G. EP.07C.10 Real-World Outcomes of Patients Treated with Neoadjuvant Immunotherapy for Resectable Non-Small Cell Lung Cancer. Journal Of Thoracic Oncology 2024, 19: s543-s544. DOI: 10.1016/j.jtho.2024.09.1007.Peer-Reviewed Original ResearchMA04.12 Uncovering Disparities and Trends in Lung Cancer Screening Based on Patient Race and Insurance Status
Zolfaghari E, Tseng R, Sather P, Ermer T, Mase V, Detterbeck F, Tanoue L, Woodard G. MA04.12 Uncovering Disparities and Trends in Lung Cancer Screening Based on Patient Race and Insurance Status. Journal Of Thoracic Oncology 2024, 19: s68. DOI: 10.1016/j.jtho.2024.09.123.Peer-Reviewed Original ResearchSpatial Transcriptomics in Inflammatory Skin Diseases Using GeoMx Digital Spatial Profiling: A Practical Guide for Applications in Dermatology
Cho C, Haddadi N, Kidacki M, Woodard G, Shakiba S, Yıldız-Altay Ü, Richmond J, Vesely M. Spatial Transcriptomics in Inflammatory Skin Diseases Using GeoMx Digital Spatial Profiling: A Practical Guide for Applications in Dermatology. JID Innovations 2024, 5: 100317. PMID: 39559817, PMCID: PMC11570843, DOI: 10.1016/j.xjidi.2024.100317.Peer-Reviewed Original ResearchDigital spatial profilingInflammatory skin diseaseGeoMx Digital Spatial ProfilerSkin diseasesDiscoid lupus erythematosusNanoString GeoMx Digital Spatial ProfilingImmune milieuImmune microenvironmentLichen planusLupus erythematosusSingle cell RNA sequencingAberrant inflammationCell RNA sequencingSkin disease pathogenesisDisease pathogenesisManufacturer's guidelinesIndicators of diseaseDiseaseSpatial transcriptomics platformSkinTissue processingFurther insights into MARS 2
Zhan P, Boffa D, Woodard G. Further insights into MARS 2. The Lancet Respiratory Medicine 2024, 12: e52. PMID: 39214641, DOI: 10.1016/s2213-2600(24)00251-0.Peer-Reviewed Original ResearchShades of Gray: Do Never Smokers Benefit From Lung Cancer Screening Programs?
Woodard G, Jablons D. Shades of Gray: Do Never Smokers Benefit From Lung Cancer Screening Programs? Journal Of Thoracic Oncology 2024, 19: 1135-1137. PMID: 39111999, DOI: 10.1016/j.jtho.2024.06.007.Peer-Reviewed Original ResearchGender representation trends in cardiothoracic surgery journal editorial boards
Higaki A, Papageorge M, Waldron C, Huggins L, Brinker M, Erez E, Milewski R, Woodard G, Antonoff M, Lee M. Gender representation trends in cardiothoracic surgery journal editorial boards. Journal Of Thoracic And Cardiovascular Surgery 2024, 168: 1570-1580.e1. PMID: 38944272, DOI: 10.1016/j.jtcvs.2024.06.019.Peer-Reviewed Original ResearchThe Proposed Ninth Edition TNM Classification of Lung Cancer
Detterbeck F, Woodard G, Bader A, Dacic S, Grant M, Park H, Tanoue L. The Proposed Ninth Edition TNM Classification of Lung Cancer. CHEST Journal 2024, 166: 882-895. PMID: 38885896, DOI: 10.1016/j.chest.2024.05.026.Peer-Reviewed Original ResearchImage-guided and bronchoscopic localization techniques used to facilitate minimally invasive pulmonary metastasectomies
Wang A, Rosenberg G, Woodard G, Dhanasopon A, Udelsman B. Image-guided and bronchoscopic localization techniques used to facilitate minimally invasive pulmonary metastasectomies. Video-Assisted Thoracic Surgery 2024, 0: 0-0. DOI: 10.21037/vats-23-80.Peer-Reviewed Original ResearchShould the TNM Staging of NSCLC Evolve Beyond Anatomical Descriptors?
Woodard G, Dacic S. Should the TNM Staging of NSCLC Evolve Beyond Anatomical Descriptors? Journal Of Thoracic Oncology 2024, 19: 663-665. PMID: 38719420, DOI: 10.1016/j.jtho.2024.01.004.Peer-Reviewed Original Research
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply